company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2010.0,Q3,2010-07-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10262000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10262000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,473000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1154000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,210000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8425000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8425000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-70000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-13166000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2010.0,Q3,2010-07-01,2010-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-13236000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-13236000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1083000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,15000000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,39000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,13956000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,13956000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2010.0,Q3,2010-07-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7705000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2010.0,Q3,2010-07-01,2010-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,32000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8823000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8823000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,463000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,648000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-500000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8212000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8212000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-27000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-17703000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,17250000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2010.0,Q4,2010-10-01,2010-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-480000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-480000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-87000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-3277000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,8460000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5096000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5096000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2010.0,Q4,2010-10-01,2010-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3596000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2010.0,Q4,2010-10-01,2010-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,458000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 06:09:33+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11401000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 06:09:33+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11401000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 06:09:33+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,439000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 06:09:33+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1569000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 06:09:33+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3390000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 06:09:33+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12839000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 06:09:33+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12839000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 06:09:33+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-10000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 06:09:33+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-14534000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 06:09:33+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,11342000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 06:09:33+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3202000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 06:09:33+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3202000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 06:09:33+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-87000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 06:09:33+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,2000000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 06:09:33+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,190000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 06:09:33+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2103000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 06:09:33+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2103000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 06:09:33+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-13938000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 06:09:33+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,371000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q2,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12502000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12502000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,384000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,430000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-522000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12154000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12154000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-35000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-25129000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,11000000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q2,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-14164000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-14164000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-181000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,35018000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,34837000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,34837000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q2,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,8519000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q2,2011-04-01,2011-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,376000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12734000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12734000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,350000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1006000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-443000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11821000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11821000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-263000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-7331000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,14302000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q3,2011-07-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,6708000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,6708000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-155000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,20000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-135000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-135000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q3,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5248000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q3,2011-07-01,2011-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,717000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10743000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10743000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,291000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,679000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-713000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10486000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10486000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-382000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3732000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,24101000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,19987000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,19987000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-156000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,87000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-69000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-69000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,9432000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q4,2011-10-01,2011-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,447000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 06:09:33+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15051000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 06:09:33+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15051000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 06:09:33+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,230000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 06:09:33+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1993000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 06:09:33+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2426000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 06:09:33+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15254000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 06:09:33+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15254000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 06:09:33+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-147000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 06:09:33+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-22824000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 06:09:33+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,9650000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 06:09:33+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-13321000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 06:09:33+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-13321000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 06:09:33+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-154000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 06:09:33+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,28204000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 06:09:33+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,5000000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 06:09:33+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,33050000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 06:09:33+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,33050000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 06:09:33+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,4475000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 06:09:33+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,501000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14620000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14620000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,223000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,500000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,802000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13095000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13095000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-65000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,67000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3695000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,3697000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,3697000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-157000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,5598000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-5000000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,441000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,441000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-8957000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q2,2012-04-01,2012-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,406000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,0.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13263000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13263000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-209000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-23130000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,16500000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-6839000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-6839000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1966000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,25917000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,23951000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,23951000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3849000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q3,2012-07-01,2012-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,428000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18123000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18123000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,115000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2005000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3430000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12523000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12523000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-84000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4146000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,10750000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,6520000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,6520000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1969000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-32000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,60074000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,58073000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,58073000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,52070000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q4,2012-10-01,2012-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,361000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q1,2013-01-01,2013-03-31,2013-04-30 06:05:16+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20728000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q1,2013-01-01,2013-03-31,2013-04-30 06:05:16+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20728000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q1,2013-01-01,2013-03-31,2013-04-30 06:05:16+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,100000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q1,2013-01-01,2013-03-31,2013-04-30 06:05:16+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1356000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q1,2013-01-01,2013-03-31,2013-04-30 06:05:16+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2942000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q1,2013-01-01,2013-03-31,2013-04-30 06:05:16+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-22214000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q1,2013-01-01,2013-03-31,2013-04-30 06:05:16+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-22214000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q1,2013-01-01,2013-03-31,2013-04-30 06:05:16+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-276000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q1,2013-01-01,2013-03-31,2013-04-30 06:05:16+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-55290000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q1,2013-01-01,2013-03-31,2013-04-30 06:05:16+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,18950000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q1,2013-01-01,2013-03-31,2013-04-30 06:05:16+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-36616000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q1,2013-01-01,2013-03-31,2013-04-30 06:05:16+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-36616000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q1,2013-01-01,2013-03-31,2013-04-30 06:05:16+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1975000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q1,2013-01-01,2013-03-31,2013-04-30 06:05:16+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,13210000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q1,2013-01-01,2013-03-31,2013-04-30 06:05:16+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1045000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q1,2013-01-01,2013-03-31,2013-04-30 06:05:16+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,12280000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q1,2013-01-01,2013-03-31,2013-04-30 06:05:16+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,12280000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q1,2013-01-01,2013-03-31,2013-04-30 06:05:16+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-46550000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q1,2013-01-01,2013-03-31,2013-04-30 06:05:16+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,789000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22787000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22787000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,125000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2601000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,142000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-19919000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-19919000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-395000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5994000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,25009000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,18620000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,18620000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-196000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,290000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,26000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,120000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,120000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1179000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q2,2013-04-01,2013-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,533000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22515000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22515000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,148000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4124000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1655000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16588000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16588000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-16000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-9899000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,18408000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,8493000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,8493000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-222000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,11000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-211000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-211000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-8306000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q3,2013-07-01,2013-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,596000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24162000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24162000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,143000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3595000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1734000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-18690000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-18690000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-82000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-42968000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,27900000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-15150000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-15150000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-237000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,57090000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,56853000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,56853000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,23013000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q4,2013-10-01,2013-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,594000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 06:10:59+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23557000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 06:10:59+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23557000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 06:10:59+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,168000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 06:10:59+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4667000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 06:10:59+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1548000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 06:10:59+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-20270000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 06:10:59+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-20270000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 06:10:59+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-23000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 06:10:59+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3548000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 06:10:59+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,19768000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 06:10:59+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,16197000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 06:10:59+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,16197000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 06:10:59+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2501000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 06:10:59+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,10118000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 06:10:59+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,7617000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 06:10:59+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,7617000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 06:10:59+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3544000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q1,2014-01-01,2014-03-31,2014-05-08 06:10:59+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,560000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q2,2013-10-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22286000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q2,2013-10-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22286000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q2,2013-10-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,169000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q2,2013-10-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2012000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q2,2013-10-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-769000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q2,2013-10-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-20874000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q2,2013-10-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-20874000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q2,2013-10-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-25000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q2,2013-10-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-14167000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q2,2013-10-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,25670000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q2,2013-10-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,11478000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q2,2013-10-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,11478000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q2,2013-10-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2374000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q2,2013-10-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,56547000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q2,2013-10-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,54173000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q2,2013-10-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,54173000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q2,2013-10-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,44777000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q2,2013-10-01,2014-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,495000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q3,2013-10-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19966000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q3,2013-10-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19966000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q3,2013-10-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,167000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q3,2013-10-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2855000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q3,2013-10-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1622000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q3,2013-10-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-18566000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q3,2013-10-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-18566000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q3,2013-10-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-37000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q3,2013-10-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-50795000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q3,2013-10-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,15250000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q3,2013-10-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-35582000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q3,2013-10-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-35582000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q3,2013-10-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2307000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q3,2013-10-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,28122000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q3,2013-10-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,25815000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q3,2013-10-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,25815000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q3,2013-10-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-28333000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q3,2013-10-01,2014-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,443000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q4,2013-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20352000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q4,2013-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20352000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q4,2013-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,169000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q4,2013-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-193000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q4,2013-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1161000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q4,2013-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-19215000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q4,2013-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-19215000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q4,2013-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-59000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q4,2013-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-25335000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q4,2013-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,24464000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q4,2013-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-930000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q4,2013-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-930000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q4,2013-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2310000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q4,2013-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q4,2013-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2309000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q4,2013-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2309000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q4,2013-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-22454000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q4,2013-10-01,2014-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,377000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 08:31:55+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20707000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 08:31:55+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20707000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 08:31:55+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,169000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 08:31:55+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1904000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 08:31:55+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-201000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 08:31:55+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-18775000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 08:31:55+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-18775000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 08:31:55+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-28683000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 08:31:55+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,37000000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 08:31:55+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,8317000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 08:31:55+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,8317000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 08:31:55+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2311000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 08:31:55+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2311000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 08:31:55+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2311000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 08:31:55+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-12769000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 08:31:55+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,325000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19800000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19800000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,168000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3060000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1098000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-17730000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-17730000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-27000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-50240000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,27248000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-23019000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-23019000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2313000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,41810000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,39497000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,39497000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1252000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q2,2015-04-01,2015-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,267000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q3,2014-10-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,35544906.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q3,2014-10-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,35544906.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q3,2014-10-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,-337000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q3,2014-10-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-2271977.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q3,2014-10-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1523562.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q3,2014-10-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,34459491.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q3,2014-10-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,34459491.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q3,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,27000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q3,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,78923000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q3,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,-64248000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q3,2014-10-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,14702000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q3,2014-10-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,14702000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q3,2014-10-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,4624000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q3,2014-10-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1450000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q3,2014-10-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-41810000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q3,2014-10-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,500000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q3,2014-10-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-35236000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q3,2014-10-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-35236000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q3,2014-10-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,13925491.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q3,2014-10-01,2015-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,-592000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q4,2014-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1882769.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q4,2014-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1882769.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q4,2014-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,919908.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q4,2014-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-133453.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q4,2014-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-1096314.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q4,2014-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1096314.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q4,2014-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1350000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q4,2014-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,6.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q4,2014-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1350006.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q4,2014-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1350006.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q4,2014-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,253692.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q1,2016-01-01,2016-03-31,2017-05-11 16:32:12+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1713000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q1,2016-01-01,2016-03-31,2017-05-11 16:32:12+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1713000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q1,2016-01-01,2016-03-31,2017-05-11 16:32:12+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,975000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q1,2016-01-01,2016-03-31,2017-05-11 16:32:12+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,300000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q1,2016-01-01,2016-03-31,2017-05-11 16:32:12+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-438000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q1,2016-01-01,2016-03-31,2017-05-11 16:32:12+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-438000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q1,2016-01-01,2016-03-31,2017-05-11 16:32:12+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,750000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q1,2016-01-01,2016-03-31,2017-05-11 16:32:12+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,750000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q1,2016-01-01,2016-03-31,2017-05-11 16:32:12+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,750000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q1,2016-01-01,2016-03-31,2017-05-11 16:32:12+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,312000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8190000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8190000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,142000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-5734000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5064000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-18846000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-18846000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-41399000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,266000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,40825000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-308000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-308000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4618000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-750000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-5368000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-5368000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-24522000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q2,2016-04-01,2016-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,923000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q3,2015-10-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8735589.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q3,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8735589.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q3,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,-142000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q3,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,14081801.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q3,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1752201.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q3,2015-10-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,6956413.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q3,2015-10-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,6956413.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q3,2015-10-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1476.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q3,2015-10-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,38404302.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q3,2015-10-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,216440.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q3,2015-10-01,2016-09-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,5849278.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q3,2015-10-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,-32246154.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q3,2015-10-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,12222390.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q3,2015-10-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,12222390.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q3,2015-10-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,4618000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q3,2015-10-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,8500250.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q3,2015-10-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,13118250.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q3,2015-10-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,13118250.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q3,2015-10-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,32297053.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q3,2015-10-01,2016-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,-923000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q4,2015-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7749411.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q4,2015-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7749411.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q4,2015-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,569199.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q4,2015-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1899799.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q4,2015-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5280413.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q4,2015-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5280413.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q4,2015-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1524.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q4,2015-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-7702302.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q4,2015-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,215560.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q4,2015-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,-278.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q4,2015-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,17484154.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q4,2015-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,83000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q4,2015-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,10078610.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q4,2015-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,10078610.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q4,2015-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-250.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q4,2015-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,5954000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q4,2015-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5953750.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q4,2015-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5953750.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q4,2015-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,10751947.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 06:03:30+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5999000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 06:03:30+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5999000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 06:03:30+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,0.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 06:03:30+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,602000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 06:03:30+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1626000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 06:03:30+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3771000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 06:03:30+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3771000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 06:03:30+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 06:03:30+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-22119000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 06:03:30+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,11563000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 06:03:30+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-10558000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 06:03:30+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-10558000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 06:03:30+00:00,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,0.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 06:03:30+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3399000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 06:03:30+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3399000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 06:03:30+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3399000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 06:03:30+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-10930000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8347000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8347000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,676000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,7000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7656000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7650000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-123000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-8994000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,8470000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-647000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-647000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,38278000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-3399000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,34879000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,34879000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,26582000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8363000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8363000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,9000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1029000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2380000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4945000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4951000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3797000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,-13089000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-16886000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-16886000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-21837000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8445000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8445000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,60000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,947000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1493000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5945000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5945000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-35301000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,41386000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,6085000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,6085000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,135527000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,135527000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,135527000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,135667000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 06:03:30+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6364000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 06:03:30+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6364000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 06:03:30+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,23000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 06:03:30+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1167000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 06:03:30+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3470000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 06:03:30+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8644000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 06:03:30+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8644000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 06:03:30+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 06:03:30+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-122193000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 06:03:30+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,20071000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 06:03:30+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-102123000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 06:03:30+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-102123000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 06:03:30+00:00,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,0.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 06:03:30+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,265000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 06:03:30+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,265000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 06:03:30+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,265000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 06:03:30+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-110502000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6460000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6460000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,24000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2227000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1145000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5354000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5360000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-129676000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,48763000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-80913000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-80913000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,313009000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,313009000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,313009000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,226736000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8512000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8512000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,24000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2322000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,922000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5244000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5238000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-13000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-273066000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,51051000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-222028000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-222028000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,311825000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-313274000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1900000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,451000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,451000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-226815000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11475000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11475000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,25000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4100000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1085000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6265000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6265000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-8000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-89423000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,114419000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,24988000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,24988000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2510000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1900000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,610000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,610000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,19333000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 06:03:28+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15080000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 06:03:28+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15080000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 06:03:28+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,28000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 06:03:28+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5976000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 06:03:28+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2598000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 06:03:28+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6478000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 06:03:28+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6478000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 06:03:28+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-41000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 06:03:28+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-173837000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 06:03:28+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,170387000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 06:03:28+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3491000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 06:03:28+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3491000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 06:03:28+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,83000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 06:03:28+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-9886000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19699000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19699000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,28000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8069000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,62000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11540000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11540000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,1000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-92279000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,128716000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,36438000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,36438000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,117000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,25015000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21429000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21429000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,28000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6256000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3821000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11324000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11324000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,2000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-140957000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,169222000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,28267000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,28267000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,35000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,35000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,35000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,16978000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27740000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27740000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,28000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6105000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,9325000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12282000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12282000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-134000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-212230000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,181857000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-30507000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-30507000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-42789000.0
